Curious about experimental approaches that clear dysfunctional aging cells while promoting regeneration? This article assesses recent preclinical research, methods, and translational caveats.
Key Takeaways
- Study used accelerated-aging and organ-injury mouse models rather than natural aging
- Researchers employed a senolytic vaccine instead of small-molecule senolytic drugs
- Combining senolytic immunotherapy with personalized MSCs markedly extended healthspan and lifespan